BamSEC and AlphaSense Join Forces
Learn More

Sucampo Pharmaceuticals, Inc.

Formerly NASDAQ: SCMP
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.2
from 8-K 5 pages Sucampo Pharmaceuticals, Inc. and U.S. Bank National Association, as Trustee First Supplemental Indenture Dated as of February 13, 2018 3.25% Convertible Senior Notes Due 2021
12/34/56
EX-4.6
from S-3 21 pages Sucampo Pharmaceuticals, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Sucampo Pharmaceuticals, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.5
from S-3 24 pages Sucampo Pharmaceuticals, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Sucampo Pharmaceuticals, Inc. Form of Preferred Stock Warrant Agreement
12/34/56
EX-4.4
from S-3 23 pages Sucampo Pharmaceuticals, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Sucampo Pharmaceuticals, Inc. Form of Common Stock Warrant Agreement
12/34/56
EX-4.2
from S-3 54 pages Sucampo Pharmaceuticals, Inc., Issuer and [Trustee], Trustee Indenture Dated as of Debt Securities
12/34/56
EX-4.1
from 8-K 97 pages Sucampo Pharmaceuticals, Inc. and U.S. Bank National Association, as Trustee Indenture Dated as of December 27, 2016 3.25% Convertible Senior Notes Due 2021
12/34/56
EX-4.7
from S-8 7 pages Sucampo Pharmaceuticals, Inc. 2016 Equity Incentive Plan Non-Employee Director Restricted Stock Unit Award Grant Notice
12/34/56
EX-4.6
from S-8 15 pages Sucampo Pharmaceuticals, Inc. Stock Option Grant Notice
12/34/56
EX-4.3
from S-3 41 pages Sucampo Pharmaceuticals, Inc., Issuer and [ ], Trustee Indenture Dated as of [ ], 20[ ] Debt Securities
12/34/56
EX-4.1
from S-1/A 3 pages Of the Class a Common Stock Represented by the Within Certificate, and Do Hereby Irrevocably Constitute and Appoint
12/34/56